Natural history of chronic hepatitis B virus infection in childhood and efficacy of interferon therapy

References

• TKoyama, IMatsuda, SSato, HYoshizawa. Prevention of perinatal hepatitis B virus transmission by combined passive-active immunoprophylaxis in Iwate, Japan (1981-1992) and epidemiological evidence for its efficacy. Hepatol Res 2003;26:287–92.
   PubMed Web of Science ®Google Scholar
• AKimura, MMatsuyuki, KYuge, EOno, NKuriya, HKato. Natural history of Japanese children with chronic hepatitis B: seroconversion from HBeAg to anti-HBe. Acta Paediatr Jpn 1993;35:537–40.
   PubMedGoogle Scholar
• YSHsu, RNChien, CTYeh, ISSheen, HYChiou, CMChu, et al. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 2002;35:1522–7.
   PubMed Web of Science ®Google Scholar
• MHChang, DSChen, HCHsu, HYHsu, CYLee. Maternal transmission of hepatitis B virus in childhood hepatocellular carcinoma. Cancer 1989;64:2377–80.
   PubMed Web of Science ®Google Scholar
• MHChang, PJChen, JYChen, MYLai, HCHsu, DCLian, et al. Hepatitis B virus integration in hepatitis B virus-related hepatocellular carcinoma in childhood. Hepatology 1991;13:316–20.
   PubMed Web of Science ®Google Scholar
• FBortolotti, MGuido, SBartolacci, PCadrobbi, CCrivellaro, FNoventa, et al. Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study. Hepatology 2006;43:556–62.
   PubMed Web of Science ®Google Scholar
• MRuiz-Moreno, MJRua, JMolina, GMoraleda, AMoreno, JGarcia-Aguado, et al. Prospective, randomized controlled trial of interferon-alpha in children with chronic hepatitis B. Hepatology 1991;13:1035–9.
   PubMed Web of Science ®Google Scholar
• TFujisawa, HKomatsu, AInui, TSogo, YMiyagawa, SFujitsuka, et al. Long-term outcome of chronic hepatitis B in adolescents or young adults in follow-up from childhood. J Pediatr Gastroenterol Nutr 2000;30:201–6.
   PubMed Web of Science ®Google Scholar
• RIorio, AGiannattasio, FCirillo, LD’ Alessandro, AVegnente. Long-term outcome in children with chronic hepatitis B: a 24-year observation period. Clin Infect Dis 2007;45:943–9.
   PubMed Web of Science ®Google Scholar
• HVo Thi Diem, ABourgois, PBontems, PGoyens, JPButs, FNackers, et al. Chronic hepatitis B infection: long term comparison of children receiving interferon alpha and untreated controls. J Pediatr Gastroenterol Nutr 2005;40:141–5.
   PubMed Web of Science ®Google Scholar
• HYHsu, HYTsai, TCWu, CLChiang, YHNi, PJChen, et al. Interferon-alpha treatment in children and young adults with chronic hepatitis B: a long-term follow-up study in Taiwan. Liver Int 2008;28:1288–97.
   PubMed Web of Science ®Google Scholar
• MMJonas, JMizerski, IBBadia, JAAreias, KBSchwarz, NRLittle, et al. Clinical trial of lamivudine in children with chronic hepatitis B. N Engl J Med 2002;346:1706–13.
   PubMed Web of Science ®Google Scholar
• MMJonas, JMBlock, BAHaber, SJKarpen, WTLondon, KFMurray, et al. Hepatitis B Foundation. Treatment of children with chronic hepatitis B virus infection in the United States: patient selection and therapeutic options. Hepatology 2010;52:2192–205.
   PubMedGoogle Scholar
• DSChen. From hepatitis to hepatoma: lessons from type B viral hepatitis. Science 1993;262:369–70.
   PubMed Web of Science ®Google Scholar
• HYHsu, MHChang, DSChen, CYLee, JLSung. Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan. J Med Virol 1986;18:301–7.
   PubMed Web of Science ®Google Scholar
• FIchida, TTsuji, MOmata, TIchida, KInoue, TKamimura, et al. New Inuyama classification; new criteria for histological assessment of chronic hepatitis. Int Hepatol Commun 1996;6:112–19.
   Web of Science ®Google Scholar
• FBortolotti, PJara, CCrivellaro, LHierro, PCadrobbi, EFrauca, et al. Outcome of chronic hepatitis B in Caucasian children during a 20-year observation period. J Hepatol 1998;29:184–90.
   PubMed Web of Science ®Google Scholar
• SELivingston, JPSimonetti, LRBulkow, CEHoman, MMSnowball, HHCagle, et al. Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F. Gastroenterology 2007;133:1452–7.
   PubMed Web of Science ®Google Scholar
• MFYuen, HJYuan, CKHui, DKWong, WMWong, AOChan, et al. A large population study of spontaneous HBeAg seroconversion and acute exacerbation of chronic hepatitis B infection: implications for antiviral therapy. Gut 2003;52:416–19.
   PubMed Web of Science ®Google Scholar
• XGuo, YZhang, JLi, JMa, ZWei, WTan, et al. Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population. Hepatology 2011;53:422–8.
   PubMed Web of Science ®Google Scholar
• KSugiyama, KGoto, YMiyake, TAndo, FMizutani, KTerabe, et al. Hepatitis B core promoter or precore gene mutations related to age at seroconversion from hepatitis B e antigen to anti-hepatitis B e in Japanese children. Pediatr Infect Dis J 2000;19:1101–3.
   PubMed Web of Science ®Google Scholar
• MRuiz-Moreno, MJRua, JMolina, GMoraleda, AMoreno, JGarcia-Aguado, et al. Prospective, randomized controlled trial of interferon-alpha in children with chronic hepatitis B. Hepatology 1991;13:1035–9.
   PubMed Web of Science ®Google Scholar
• BBurczynska, KMadalinski, JPawlowska, MWoynarowski, JSocha, WHGerlich, et al. The value of quantitative measurement of HBeAg and HBsAg before interferon-alpha treatment of chronic hepatitis B in children. J Hepatol 1994;21:1097–102.
   PubMed Web of Science ®Google Scholar
• YJ GastMiyake, HKobashi, KYamamoto. Meta-analysis: the effect of interferon on development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. J Gastroenterol 2009;44:470–5.
   PubMed Web of Science ®Google Scholar
• YFYang, WZhao, YDZhong, HMXia, LShen, NZhang. Interferon therapy in chronic hepatitis B reduces progression to cirrhosis and hepatocellular carcinoma: a meta-analysis. J Viral Hepat 2009;16:265–71.
   PubMed Web of Science ®Google Scholar
• SIshiguro, MInoue, YTanaka, MMizokami, MIwasaki, STsugane; JPHC Study Group. Serum aminotransferase level and the risk of hepatocellular carcinoma: a population-based cohort study in Japan. Eur J Cancer Prev 2009;18:26–32.
   PubMed Web of Science ®Google Scholar
• CJChen, HIYang, JSu, CLJen, SLYou, SNLu, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006;295:65–73.
   PubMed Web of Science ®Google Scholar